Ali, Anum
Zambrano, Ronald
Duncan, Matthew R.
Chen, Shaoyi
Luo, Shihua
Yuan, Huijun
Chen, Pingping
Benny, Merline
Schmidt, Augusto
Young, Karen
Kerr, Nadine
de Rivero Vaccari, Juan Pablo
Keane, Robert W.
Dietrich, W. Dalton
Wu, Shu
Article History
Received: 5 November 2020
Accepted: 16 March 2021
First Online: 22 April 2021
Change Date: 6 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-021-99450-2
Competing interests
: JPdRV, WDD and RWK are co-founders and managing members of InflamaCORE, LLC and have licensed patents on inflammasome proteins as biomarkers of injury and disease as well as on targeting inflammasome proteins for therapeutic purposes. JPdRV, WDD and RWK are Scientific Advisory Board Members of ZyVersa Therapeutics.